Beta Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beta Drugs Limited's registrar, MUFG Intime India Private Limited, has submitted a routine compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. The certificate confirms that securities received from depository participants for dematerialisation during the quarter ended 30th September 2025 were duly processed, with listed status confirmed on stock exchanges. It also notes that no dematerialisation requests were received from shareholders during the quarter. The filing is purely for regulatory compliance purposes.
This is a routine administrative filing with no impact on the company's financials, operations, or stock price. It simply confirms standard registrar compliance with SEBI dematerialisation rules.